A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus

Autoimmunity Reviews

Volumn 15, Issue 2, 2016, Pages 124-138

  Ho, Roger C ^a   Thiaghu, C ^a   Ong, Huiyi ^a   Lu, Yanxia ^b   Ho, Cyrus S ^a   Tam, Wilson W ^a   Zhang, Melvyn W ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

Adjunct diagnostic tool; Autoantibody; Neuropsychiatric systemic lupus erythematosus (NPSLE)

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT ANTIBODY; NEURONAL ANTIBODY; PHOSPHOLIPID ANTIBODY; RIBOSOMAL P ANTIBODY; UNCLASSIFIED DRUG;

AGE; ANTIBODY TITER; CEREBROSPINAL FLUID; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONFUSION; CORRELATION ANALYSIS; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DISEASE DURATION; HEADACHE; HUMAN; META ANALYSIS; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; POLYNEUROPATHY; PSYCHOSIS; REGRESSION ANALYSIS; REVIEW; SEIZURE; SERUM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; BLOOD; IMMUNOLOGY; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PREVALENCE;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; PREVALENCE;

EID: 84954389233     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.10.003     Document Type: Review

References (70)

1. Greenwood D.L.V., Gitlits V.M., Alderuccio F., Sentry J.W., Toh B.-H. Autoantibodies in neuropsychiatric lupus. Autoimmunity 2002, 35:79-86. 10.1080/08916930290016547.
2. Yaniv G., Twig G., Shor D.B.-A., et al. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients. Autoimmun Rev 2015, 14:75-79. 10.1016/j.autrev.2014.10.003.
3. To C.H., Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?. Arthritis Rheum 2005, 52:4003-4010. 10.1002/art.21414.
4. Hanly J.G., Harrison M.J. Management of neuropsychiatric lupus. Best Pract Res Clin Rheumatol 2005, 19:799-821. 10.1016/j.berh.2005.04.003.
5. Libbey J.E., Fujinami R.S. Role for antibodies in altering behavior and movement. Autism Res 2010, 3:147-152. 10.1002/aur.144.
6. Tsuchiya H., Haga S., Takahashi Y., et al. Identification of novel autoantibodies to GABAB receptors in patients with neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 2014, 53:1219-1228. 10.1093/rheumatology/ket481.
7. Bresnihan B., Hohmeister R., Cutting J., et al. The neuropsychiatric disorder in systemic lupus erythematosus: evidence for both vascular and immune mechanisms. Ann Rheum Dis 1979, 38:301-306. 10.1136/ard.38.4.301.
8. Martinez-Cordero E., Rivera Garcia B.E., Aguilar Leon D.E. Anticardiolipin antibodies in serum and cerebrospinal fluid from patients with systemic lupus erythematosus. J Investig Allergol Clin Immunol 1997, 7:596-601.
9. Mostafa G.A., Nazif H.K., El-Shahawi H.H., Abd El-Aziz M.M., Hassan M.A. Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus. Pediatr Allergy Immunol 2009, 20:192-199. 10.1111/j.1399-3038.2008.00753.x.
10. Hanly J.G. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheumatol 2014, 10:338-347. 10.1038/nrrheum.2014.15.
11. Postal M., Costallat L.T.L., Appenzeller S. Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management. CNS Drugs 2011, 25:721-736. 10.2165/11591670-000000000-00000.
12. Weiner S.M., Klein R., Berg P.A. A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases. Rheumatol Int 2000, 19:83-88. 10.1007/s002960050108.
13. Costallat L.T.L., De Oliveira R.M., Santiago M.B., Cossermelli W., Samara A.M. Neuropsychiatric manifestations of systemic lupus erthematosus: the value of anticardiolipin, antigangliosides and antigalactocerebrosides antibodies. Clin Rheumatol 1990, 9:489-497. 10.1007/BF02030510.
14. Popescu A.H., Kao A. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol 2011, 9:449-457. 10.2174/157015911796557984.
15. Tin S.K., Xu Q., Thumboo J., et al. Novel brain reactive autoantibodies: prevalence in systemic lupus erythematosus and association with psychoses and seizures. J Neuroimmunol 2005, 169:153-160. 10.1016/j.jneuroim.2005.07.015.
16. Schneebaum A.B., Singleton J.D., West S.G., et al. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med 1991, 90:54-62. 10.1016/0002-9343(91)90506-S.
17. Stojanovich L., Zandman-Goddard G., Pavlovich S., Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007, 6:421-426. 10.1016/j.autrev.2007.02.007.
18. Bonfa E., Golombek S.J., Kaufman L.D., et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987, 317:265-271. 10.1056/NEJM198707303170503.
19. Teh L.S., Isenberg D.A. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum. 1994, 37:307-315.
20. Eber T., Chapman J., Shoenfeld Y. Anti-ribosomal P-protein and its role in psychiatric manifestations of systemic lupus erythematosus: myth or reality?. Lupus 2005, 14:571-575. 10.1191/0961203305lu2150rr.
21. Kiss E., Shoenfeld Y. Are anti-ribosomal P protein antibodies relevant in systemic lupus erythematosus?. Clin Rev Allergy Immunol 2007, 32:37-46. 10.1007/s12016-007-0018-7.
22. Karassa F.B., Afeltra A., Ambrozic A., et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006, 54:312-324. 10.1002/art.21539.
23. Hanly J.G., Hong C., Smith S., Fisk J.D. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999, 42:728-734. 10.1002/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O.
24. Efthimiou P., Blanco M. Pathogenesis of neuropsychiatric systemic lupus erythematosus and potential biomarkers. Mod Rheumatol 2009, 19:457-468. 10.1007/s10165-009-0198-5.
25. Omdal R., Brokstad K., Waterloo K., et al. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005, 12:392-398. 10.1111/j.1468-1331.2004.00976.x.
26. Hanly J.G., Robichaud J., Fisk J.D. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006, 33:1553-1558.
27. Harrison M.J., Ravdin L.D., Lockshin M.D. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006, 54:2515-2522. 10.1002/art.22030.
28. Li P.H., Wong W.H.S., Lee T.L., et al. Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford) 2013, 52:337-345. 10.1093/rheumatology/kes261.
29. Fragoso-Loyo H., Cabiedes J., Orozco-Narvaez A., et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008, 3:e3347.
30. Ezeoke A., Mellor A., Buckley P., Miller B. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res 2013, 150:245-251. 10.1016/j.schres.2013.07.029.
31. Koh W.H., Fong K.Y., Boey M.L., Feng P.H. Systemic lupus erythematosus in 61 Oriental males. A study of clinical and laboratory manifestations. Br J Rheumatol 1994, 33:339-342.
32. Ad A.C.R., Committee H.O.C., Neuropsychiatric O.N., Nomenclature L. The American Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42:599-608.
33. Miyakis S., Lockshin M.D., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295-306. 10.1111/j.1538-7836.2006.01753.x.
34. Toubi E., Khamashta M.A., Panarra A., Hughes G.R. Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. Am J Med 1995, 99:397-401. [doi:S0002-9343(99)80188-0 ,pii].
35. Silva L.M., Donadi E.A. Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE?. Ann Rheum Dis 1996, 55:544-547. 10.1136/ard.55.8.544.
36. Karassa F.B., Ioannidis J.P., Touloumi G., Boki K.A., Moutsopoulos H.M. Risk factors for central nervous system involvement in systemic lupus erythematosus. QJM 2000, 93:169-174.
37. Mok C.C., Lau C.S., Wong R.W. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001, 28:766-771.
38. Sun X.Y., Shi J., Han L., Su Y., Li Z.G. Anti-histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupus. J Clin Lab Anal 2008, 22:271-277. 10.1002/jcla.20248.
39. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012. 10.1001/jama.283.15.2008.
40. Thompson S.G., Higgins J.P.T. How should meta-regression analyses be undertaken and interpreted?. Stat Med 2002, 21:1559-1573. 10.1002/sim.1187.
41. Toledano P., Sarbu N., Espinosa G., Bargalló N., Cervera R. Neuropsychiatric systemic lupus erythematosus: magnetic resonance imaging findings and correlation with clinical and immunological features. Autoimmun Rev 2013, 12:1166-1170. 10.1016/j.autrev.2013.07.004.
42. Sciascia S., Bertolaccini M.L., Baldovino S., et al. Central nervous system involvement in systemic lupus erythematosus: overview on classification criteria. Autoimmun Rev 2013, 12:426-429. 10.1016/j.autrev.2012.08.014.
43. Chan E.Y., Ko O.K., Lawton J.W., Lau C.S. The use of anti-ribosomal P antibodies in the diagnosis of cerebral lupus -superiority of western blotting over enzyme-linked immunosorbent assay. Hong Kong Med J 1998, 4:145-150.
44. Hawkins B.R., Wong K.L., Wong R.W., et al. Strong association between the major histocompatibility complex and systemic lupus erythematosus in southern Chinese. J Rheumatol 1987, 14:1128-1131.
45. Kittner S.J., Gorelick P.B. Antiphospholipid antibodies and stroke: an epidemiological perspective. Stroke 1992, 23:I19-I22.
46. Kaichi Y., Kakeda S., Moriya J., et al. Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome. AJNR Am J Neuroradiol 2013, 35:100-105. 10.3174/ajnr.A3645.
47. Syuto T., Shimizu A., Takeuchi Y. Association of antiphosphatidylserine / prothrombin antibodies with neuropsychiatric systemic lupus erythematosus. Clin Rheumatol 2009, 841-5. 10.1007/s10067-009-1123-1.
48. Colasanti T., Delunardo F., Margutti P., et al. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythematosus. J Neuroimmunol 2009, 212:3-9. 10.1016/j.jneuroim.2009.05.003.
49. Love P.E., Santoro S.A. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders: prevalence and clinical significance. Ann Intern Med 1990, 112:682-698.
50. Hermosillo-Romo D., Brey R.L. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE). Best Pract Res Clin Rheumatol 2002, 16:229-244. 10.1053/berh.2001.0223.
51. Georgescu L., Mevorach D., Arnett F.C., Reveille J.D., Elkon K.B. Anti-P antibodies and neuropsychiatric lupus erythematosus. Ann N Y Acad Sci 1997, 823:263-269. 10.1111/j.1749-6632.1997.tb48399.x.
52. DeGiorgio L.A., Konstantinov K.N., Lee S.C., et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001, 7:1189-1193. 10.1038/nm1101-1189.
53. Kowal C., DeGiorgio L.A., Nakaoka T., et al. Cognition and immunity: antibody impairs memory. Immunity 2004, 21:179-188. 10.1016/j.immuni.2004.07.011.
54. Husebye E.S., Sthoeger Z.M., Dayan M., et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1210-1213. 10.1136/ard.2004.029280.
55. Petri M., Naqibuddin M., Sampedro M., Omdal R., Carson K.A. Memantine in systemic lupus erythematosus: a randomized, double-blind placebo-controlled trial. Semin Arthritis Rheum 2011, 41:194-202. 10.1016/j.semarthrit.2011.02.005.
56. Zardi E.M., Taccone A., Marigliano B., Margiotta D.P.E., Afeltra A. Neuropsychiatric systemic lupus erythematosus: tools for the diagnosis. Autoimmun Rev 2014, 13:831-839. 10.1016/j.autrev.2014.04.002.
57. Sarbu N., Alobeidi F., Toledano P., et al. Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort. Autoimmun Rev 2015, 14:153-159. 10.1016/j.autrev.2014.11.001.
58. Gal Y., Twig G., Mozes O., et al. Central nervous system involvement in systemic lupus erythematosus: an imaging challenge. Isr Med Assoc J 2013, 15:382-386.
59. Giles I., Rahman A. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. Best Pract Res Clin Rheumatol 2009, 23:525-537. 10.1016/j.berh.2009.01.009.
60. Erkan D., Yazici Y., Peterson M.G., Sammaritano L., Lockshin M.D. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 2002, 41:924-929.
61. Mok M.Y., Chan E.Y.T., Fong D.Y.T., et al. Antiphospholipid antibody profiles and their clinical associations in Chinese patients with systemic lupus erythematosus. J Rheumatol 2005, 32:622-628.
62. Xiong Y., Wang G.-Z., Zhou J.-Q., et al. Serum antibodies to microbial antigens for Crohn's disease progression: a meta-analysis. Eur J Gastroenterol Hepatol 2014, 26:733-742. 10.1097/MEG.0000000000000102.
63. Szodoray P., Szabo Z., Kapitany A., et al. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis. Autoimmun Rev 2010, 9:140-143. 10.1016/j.autrev.2009.04.006.
64. Aran A., Lin L., Finn L.A., et al. Post-streptococcal antibodies are associated with metabolic syndrome in a population-based Cohort. PLoS One 2011, 6. 10.1371/journal.pone.0025017.
65. Conti F., Alessandri C., Bompane D., et al. Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 2004, 6:R366-R372. 10.1186/ar1198.
66. Margutti P., Sorice M., Conti F., et al. Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther 2005, 7:R896-R903. 10.1186/ar1759.
67. Borowoy A.M., Pope J.E., Silverman E., et al. Neuropsychiatric Lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. Semin Arthritis Rheum 2012, 42:179-185. 10.1016/j.semarthrit.2012.03.011.
68. Abdel-Nasser A.M., Ghaleb R.M., Mahmoud J.A., Khairy W., Mahmoud R.M. Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 2008, 27:1377-1385. 10.1007/s10067-008-0921-1.
69. Song J., Park Y.B., Lee W.K., Lee K.H., Lee S.K. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000, 20:1-7.
70. Yoshio T., Hirata D., Onda K., Nara H., Minota S. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 2005, 32:34-39. [doi: 0315162X-32-34].